Physician profile
Cindy D Patrick
NPI 1386894707
$1,382.38
in general payments reported to CMS, 2019-2025
13 companies · $315 in 2025
The $315 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $244 · 2022: $98.10 · 2023: $320 · 2024: $406 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,041.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,040.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $475.00 | 2021-2025 | |
| Inspire Medical Systems, INC. | $336.83 | 2024-2025 | Inspire |
| Novo Nordisk INC | $121.83 | 2025 | Wegovy |
| Vanda Pharmaceuticals INC. | $98.02 | 2021-2024 | Fanapt |
| Ironshore Pharmaceuticals INC. | $89.30 | 2023-2024 | Jornay Pm |
| Sunovion Pharmaceuticals INC. | $70.74 | 2021 | |
| Neurocrine Biosciences, INC. | $46.03 | 2022 | |
| Supernus Pharmaceuticals, INC. | $37.22 | 2022-2024 | Qelbree |
| Lundbeck LLC | $23.76 | 2023 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $23.56 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.15 | 2024 | Trintellix |
| Neos Therapeutics, LP | $20.66 | 2022 | |
| Axsome Therapeutics, INC. | $17.28 | 2025 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Patrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.